Correlation Between Telix Pharmaceuticals and Suncorp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Suncorp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Suncorp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals and Suncorp Group, you can compare the effects of market volatilities on Telix Pharmaceuticals and Suncorp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Suncorp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Suncorp.

Diversification Opportunities for Telix Pharmaceuticals and Suncorp

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Telix and Suncorp is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals and Suncorp Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Suncorp Group and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals are associated (or correlated) with Suncorp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Suncorp Group has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Suncorp go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Suncorp

Assuming the 90 days trading horizon Telix Pharmaceuticals is expected to generate 1.58 times more return on investment than Suncorp. However, Telix Pharmaceuticals is 1.58 times more volatile than Suncorp Group. It trades about 0.21 of its potential returns per unit of risk. Suncorp Group is currently generating about 0.06 per unit of risk. If you would invest  2,102  in Telix Pharmaceuticals on September 22, 2024 and sell it today you would earn a total of  372.00  from holding Telix Pharmaceuticals or generate 17.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy97.78%
ValuesDaily Returns

Telix Pharmaceuticals  vs.  Suncorp Group

 Performance 
       Timeline  
Telix Pharmaceuticals 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Telix Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Suncorp Group 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Suncorp Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Suncorp is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Telix Pharmaceuticals and Suncorp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telix Pharmaceuticals and Suncorp

The main advantage of trading using opposite Telix Pharmaceuticals and Suncorp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Suncorp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Suncorp will offset losses from the drop in Suncorp's long position.
The idea behind Telix Pharmaceuticals and Suncorp Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk